CLASS I ONGOING Drug recall · Reported 18 Jun 2025 · FDA Enforcement Report

Sulfamethoxazole and Trimethoprim Tablets, USP, 400 mg/80 mg recalled

Amneal Pharmaceuticals is recalling Sulfamethoxazole and Trimethoprim Tablets, USP, 400 mg/80 mg, distributed nationwide in the US. The recall was initiated on 2 Jun 2025 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot #s: a) AM241019, AM241020, Exp. 06/30/2027 b) AM241019A, Exp 06/30/2027
NDC65162-271, 65162-272
UPC0365168211102, 0365162272109
Quantity recalled6396 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0488-2025
FDA event ID
96985
Recalling firm
Amneal Pharmaceuticals, Bridgewater, NJ
Manufacturer
Amneal Pharmaceuticals LLC
Classification
Class I
Status
Ongoing
Recall initiated
2 Jun 2025
FDA classified
23 Jun 2025
Reported
18 Jun 2025
Type
Voluntary: Firm initiated
Customers notified by
Press Release
Reason category
Sterility
Drug class
Antibiotics

Timeline

2 Jun 2025Recall initiated by company
18 Jun 2025Published in enforcement report+16 days
23 Jun 2025Classified by FDA+5 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Microbial contamination of non-sterile products: tablets may exhibit black spots due to microbial contamination.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Sulfamethoxazole and Trimethoprim Tablets, USP, 400 mg/80 mg, Rx Only, a) 100 Tablets per Bottle, NDC: 65162-271-10, b) 500 Tablets per Bottle, NDC: 65162-271-50, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad, 382213, INDIA, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807.

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Microbial contamination of non-sterile products: tablets may exhibit black spots due to microbial contamination.

Which lots are affected?

Lot #s: a) AM241019, AM241020, Exp. 06/30/2027 b) AM241019A, Exp 06/30/2027

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Amneal Pharmaceuticals

All 24

Other Sulfamethoxazole recalls

All 15
ReportedClassRecallCompanyReasonWhere
DrugCLASS IISulfamethoxazole and Trimethoprim Tablets recalledSulfamethoxazole And TrimethoprimNorthwind PharmaceuticalsPackaging DefectsNationwide
DrugCLASS IISulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg recalledSulfamethoxazole And TrimethoprimThe Harvard Drug GroupPackaging DefectsNationwide
DrugCLASS IISulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg recalledSulfamethoxazole And TrimethoprimThe Harvard Drug GroupPackaging DefectsNationwide
DrugCLASS IISulfamethoxazole and Trimethoprim Tablets, USP 800mg/160mg recalledSulfamethoxazole And TrimethoprimAmneal PharmaceuticalsPackaging DefectsNationwide
DrugCLASS IISulfamethoxazole and Trimethoprim Tablets recalledSulfamethoxazole And TrimethoprimMckesson Medical-Surgical Inc. Corporate OfficeManufacturing (CGMP) DeviationsNationwide